Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endothelin-1 and Its Role in Cancer and Potential Therapeutic Opportunities
Madeline Harrison, Д. А. Зиновкин, Md Zahidul Islam Pranjol
Biomedicines (2024) Vol. 12, Iss. 3, pp. 511-511
Open Access | Times Cited: 10

Showing 10 citing articles:

Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs)
Qingjian He, Junling Lin, Chaohua Mo, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment
Jiang Hua
Cancer Management and Research (2025) Vol. Volume 17, pp. 219-237
Open Access
Altered Expression Levels of Angiogenic Peptides in the Carotid Body of Spontaneously Hypertensive Rats
Dimitrinka Atanasova, Pavel Rashev, Milena Mourdjeva, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1620-1620
Open Access
Endothelin-1 as a Candidate Biomarker of Systemic Sclerosis: A GRADE-Assessed Systematic Review and Meta-Analysis With Meta-Regression
Arduino A. Mangoni, Angelo Zinellu
Biomarker Insights (2025) Vol. 20
Open Access
The neuroscience of cancer: Focus on neuropeptidergic systems
Zi-Kai Dong, Yongfei Wang, Weilin Jin
Acta Pharmaceutica Sinica B (2025)
Open Access
Assessment of the serum level of Endothelin-1 in patients with multiple myeloma
Mary G. Naguib, Essam A. Hassan, Mohamed M. Moussa, et al.
The Egyptian Journal of Haematology (2025) Vol. 50, Iss. 1, pp. 140-145
Closed Access
Investigating the anti-carcinogenic potential action of 1,2,3 triazole core compounds: impact of introducing an aldehyde or Nitro group, integrating cell line studies, and in silico ADME and protein target prediction
Huda Ghassan Hameed, Hayder B. Sahib, Zahraa Sabbar Omran
Pharmacia (2024) Vol. 71, pp. 1-9
Open Access | Times Cited: 2
Is endothelin targeting finally ready for prime time?
Francesca Schinzari, Manfredi Tesauro, Carmine Cardillo
Clinical Science (2024) Vol. 138, Iss. 11, pp. 635-644
Closed Access | Times Cited: 1
Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis
Spyros Foutadakis, Dimitris Kordias, Giannis Vatsellas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6853-6853
Open Access | Times Cited: 1
The vasculogenic mimicry, CD146 + and CD105 + microvessel density in the prognosis of endometrioid endometrial adenocarcinoma: a single-center immunohistochemical study
Д. А. Зиновкин, Hongbo Wang, Zhicheng Yu, et al.
Biomarkers (2024) Vol. 29, Iss. 7, pp. 459-465
Closed Access
Page 1

Scroll to top